מאמרים עם הרשאות לגישה ציבורית - Jun.-Prof. Dr. Ana I. Casasלמידע נוסף
לא זמין באתר כלשהו: 1
Simultaneous determination of 8 neurotransmitters and their metabolite levels in rat brain using liquid chromatography in tandem with mass spectrometry: Application to the …
A Wojnicz, JA Ortiz, AI Casas, AE Freitas, MG Lopez, A Ruiz-Nuno
Clinica Chimica Acta 453, 174-181, 2016
הרשאות: European Commission
זמינים באתר כלשהו: 35
Network pharmacology: curing causal mechanisms instead of treating symptoms
C Nogales, ZM Mamdouh, M List, C Kiel, AI Casas, HHHW Schmidt
Trends in Pharmacological Sciences 43 (2), 136-150, 2022
הרשאות: European Commission
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
J Egea, I Fabregat, YM Frapart, P Ghezzi, A Görlach, T Kietzmann, ...
Redox biology 13, 94-162, 2017
הרשאות: US National Institutes of Health, British Heart Foundation, UK Medical …
From single drug targets to synergistic network pharmacology in ischemic stroke
AI Casas, AA Hassan, SJ Larsen, V Gomez-Rangel, M Elbatreek, ...
Proceedings of the National Academy of Sciences 116 (14), 7129-7136, 2019
הרשאות: Villum Foundation, European Commission, Government of Spain
Reactive oxygen-related diseases: therapeutic targets and emerging clinical indications
AI Casas, VTV Dao, A Daiber, GJ Maghzal, F Di Lisa, N Kaludercic, ...
Antioxidants & redox signaling 23 (14), 1171-1185, 2015
הרשאות: National Health and Medical Research Council, Australia, European Commission
NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage
AI Casas, E Geuss, PWM Kleikers, S Mencl, AM Herrmann, I Buendia, ...
Proceedings of the National Academy of Sciences 114 (46), 12315-12320, 2017
הרשאות: German Research Foundation, European Commission, Government of Spain
Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice
AE Freitas, J Egea, I Buendia, V Gómez-Rangel, E Parada, E Navarro, ...
Molecular Neurobiology 53, 3030-3045, 2016
הרשאות: Government of Spain
On the clinical pharmacology of reactive oxygen species
AI Casas, C Nogales, HAM Mucke, A Petraina, A Cuadrado, AI Rojo, ...
Pharmacological reviews 72 (4), 801-828, 2020
הרשאות: European Commission
Network medicine for disease module identification and drug repurposing with the NeDRex platform
S Sadegh, J Skelton, E Anastasi, J Bernett, DB Blumenthal, G Galindez, ...
Nature Communications 12 (1), 6848, 2021
הרשאות: German Research Foundation, European Commission, Federal Ministry of …
Pharmacology and clinical drug candidates in redox medicine
VTV Dao, AI Casas, GJ Maghzal, T Seredenina, N Kaludercic, ...
Antioxidants & redox signaling 23 (14), 1113-1129, 2015
הרשאות: National Health and Medical Research Council, Australia, European Commission
Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke
AI Casas, PWM Kleikers, E Geuss, F Langhauser, T Adler, DH Busch, ...
The Journal of clinical investigation 129 (4), 1772-1778, 2019
הרשאות: German Research Foundation, European Commission, Government of Spain …
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation
VTV Dao, MH Elbatreek, S Altenhöfer, AI Casas, MP Pachado, ...
Free Radical Biology and Medicine 148, 60-69, 2020
הרשאות: European Commission
A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection
F Langhauser, AI Casas, VTV Dao, E Guney, J Menche, E Geuss, ...
NPJ systems biology and applications 4 (1), 8, 2018
הרשאות: German Research Foundation, European Commission, Government of Spain
Early toll‐like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro‐inflammatory phenotype in rodent and human brain ischaemia models
E Parada, AI Casas, A Palomino‐Antolin, V Gómez‐Rangel, ...
British Journal of Pharmacology 176 (15), 2764-2779, 2019
הרשאות: Government of Spain
Thromboinflammation in Brain Ischemia: Recent Updates and Future Perspectives
SF De Meyer, F Langhauser, S Haupeltshofer, C Kleinschnitz, AI Casas
Stroke 53 (5), 1487-1499, 2022
הרשאות: Research Foundation (Flanders), German Research Foundation, European Commission
Time‐dependent dual effect of NLRP3 inflammasome in brain ischaemia
A Palomino‐Antolin, P Narros‐Fernández, V Farré‐Alins, ...
British Journal of Pharmacology 179 (7), 1395-1410, 2022
הרשאות: Government of Spain
NOS knockout or inhibition but not disrupting PSD-95-NOS interaction protect against ischemic brain damage
C Kleinschnitz, S Mencl, PWM Kleikers, MK Schuhmann, M G López, ...
Journal of Cerebral Blood Flow & Metabolism 36 (9), 1508-1512, 2016
הרשאות: German Research Foundation, UK Medical Research Council, European Commission
Implication of type 4 NADPH oxidase (NOX4) in tauopathy
E Luengo, P Trigo-Alonso, C Fernández-Mendívil, Á Nuñez, ...
Redox Biology 49, 102210, 2022
הרשאות: Government of Spain
Thromboinflammatory challenges in stroke pathophysiology
RD Szepanowski, S Haupeltshofer, SE Vonhof, B Frank, C Kleinschnitz, ...
Seminars in Immunopathology 45 (3), 389-410, 2023
הרשאות: German Research Foundation, European Commission, Federal Ministry of …
Platelet depletion does not alter long-term functional outcome after cerebral ischaemia in mice
RD Steubing, F Szepanowski, C David, AM Yusuf, S Mencl, AK Mausberg, ...
Brain, Behavior, & Immunity-Health 24, 100493, 2022
הרשאות: German Research Foundation
המידע על הפרסום ועל הגורמים המממנים נקבע באופן אוטומטי על ידי תוכנת מחשב